1. Шальнова С.А. Факторы риска сердечно-сосудистых заболеваний и показатели ожидаемой продолжительности жизни населения России по результатам обследования национальной представительной выборки. Дис. ... докт. мед. наук. М., 1999.
2. Агеев Ф.Т., Фомин И.В., Мареев В.Ю., Беленков Ю.Н. Распространенность артериальной гипертонии в европейской части Российской Федерации. Данные исследования ЭПОХА. Кардиология. 2002; 11: 50–3.
3. Franklin SS, Gustin IV W, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation 1997; 96: 308–15.
4. Franklin SS. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis based on National Health and Nutrition Examination Survey (NHANES III). Hypertension 2001; 37: 869–74.
5. Nichols WW, O'Rourke MF. McDonald's blood flow in arteries: theoretic, experimental and clinical principles. 5th ed. Edward Arnold, London, 2005.
6. Stout NR, Kenny RA, Baylis PH. A review of water balance in ageing in health and disease. Gerontology 1999; 45: 61–6.
7. Beck LH. Changes in renal function with aging. Clin Geriatr Med 1998; 14: 199–209.
8. Бойцов С.А., Уринский А.М., Кузнецов Р.Л., Поздняков Ю.М. Структура факторов риска, поражений органов-мишеней и метаболических изменений у больных артериальной гипертензий в различных возрастных группах. Кардиология. 2008. В печати.
9. 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2007; 25: 1105–87.
10. Neaton JD, Kuller L, Stamler J, Wentworth DN. Impact of systolic and diastolic blood pressure on cardiovascular mortali ty. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. 2nd ed. Vol. 1. New York: Raven Press, 1995; 127–44.
11. Blood Pressure-Lowering Treatment Trialists Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362: 1527–45.
12. He J, Whelton PK. Elevated systolic blood pressure as risk factor for cardiovascular and renal disease. J Hypertens 1999; 17 (suppl. 2): S7–S13.
13. Моисеев В.С., Кобалава Ж.Д. АРГУС. Артериальная гипертония у лиц старших возрастных групп. М., 2002.
14. Poulter N, Sever P. Anglo-Scandinavian Cardiac Outcomes Trial. History, results and implications for the management of high blood pressure. Birmingham: Sherborne Gibbs Ltd; 2005.
15. Gueyffier F et al. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996; 10: 1–8.
16. Gueyffier F, Bulpitt C, Boissel J-P et al. Antihypertensive drugs in very old people; a subgrope meta-analysis of randomized controlled trials. Lancet 1999; 353: 793–6.
17. Lewington S, Clarke R, Qizibash N et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002; 360: 1903–13.
18. Gosse P, Sheridane DJ, Zannad F, Karpov Y et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1,5 mg versus enalapril 20 mg: tht LIVE study. J Hypertens 2000; 18: 1465–75.